Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Magnesium Chloride Anhydrous SCHEMBL28223609 | 0.92 | NQO1 (0.46) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL21268379 | 0.88 | NQO1 (0.46) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL17046398 | 0.88 | NQO1 (0.46) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL2454340 | 0.88 | NQO1 (0.50) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL2893194 | 0.88 | NQO1 (0.44) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL21268325 | 0.85 | KDM4E (0.44) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL21268441 | 0.84 | NQO1 (0.42) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL16950817 | 0.83 | NQO1 (0.45) | NQO1TSHRTDP1LTA4HKDM4E | |
| SCHEMBL4915707 | 0.81 | L3MBTL1 (0.44) | NQO1TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL15352558 | 0.81 | NQO1 (0.39) | NQO1TSHRTDP1LTA4HALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116874495-A | Pyrido dihydrofuranone derivative and preparation method and application thereof | 中山大学 | 2023-10-13 | — | — | CN | claimed |
| US-20210138117-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2021-05-13 | — | — | US | claimed |
| EP-3038621-B1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RES INSTITUTE (US) | 2020-12-02 | — | — | EP | claimed |
| CN-109678759-A | Organic blue fluorescent material of a kind of D-A type based on dianthracene and its preparation method and application | 陕西师范大学 | 2019-04-26 | — | — | CN | claimed |
| EP-3428202-A1 | PROCESS OF PRODUCING POLYOLEFINS USING METALLOCENE POLYMERIZATION CATALYSTS AND COPOLYMERS THEREFROM | ExxonMobil Chemical Patents Inc. (US) | 2019-01-16 | — | — | EP | claimed |
| CN-105263969-B | Using metallocene polymerization catalyst preparation polyolefin and the method for copolymer | 埃克森美孚化学专利公司 | 2017-04-05 | — | — | CN | claimed |
| US-9611348-B2 | Process of producing polyolefins using metallocene polymerization catalysts and copolymers therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-04-04 | — | — | US | claimed |
| EP-3038621-A2 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | Human Biomolecular Research Institute (US) | 2016-07-06 | — | — | EP | claimed |
| EP-2984111-A1 | PROCESS OF PRODUCING POLYOLEFINS USING METALLOCENE POLYMERIZATION CATALYSTS AND COPOLYMERS THEREFROM | ExxonMobil Chemical Patents Inc. (US) | 2016-02-17 | — | — | EP | claimed |
| US-20160038641-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2016-02-11 | — | — | US | claimed |
| WO-1995006034-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1995-03-02 | — | — | WO | claimed |
| US-5041651-A | Produced by reacting optically active aminoalcohol or salt with borane or metal borohydride | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-08-20 | — | — | US | claimed |
| US-4923999-A | Optically active borane complex and a method for producing an optically active alcohol derivative by the use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-05-08 | — | — | US | claimed |
| EP-0171175-B1 | AN OPTICALLY ACTIVE BORANE COMPLEX AND A METHOD FOR PRODUCING AN OPTICALLY ACTIVE ALCOHOL DERIVATIVE BY THE USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-05-24 | — | — | EP | claimed |
| US-4760149-A | Asymmetrically reducing a ketone with an asymmetrically modified borohydride compound obtained by reacting a borohydride with optically active amino alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-07-26 | — | — | US | claimed |
| US-4749809-A | Optically active borane complex and a method for producing an optically active alcohol derivative by the use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-06-07 | — | — | US | claimed |
| US-4716168-A | STIMULANTS OF IMMUNE RESPONSE | NORWICH EATON PHARMACEUTICALS, INC. (US) | 1987-12-29 | — | — | US | claimed |
| EP-0187705-A2 | Imidazo(4,5-f)quinolines useful as immunomodulating agents | Norwich Eaton Pharmaceuticals, Inc. (US) | 1986-07-16 | — | — | EP | claimed |
| EP-0171175-A1 | An optically active borane complex and a method for producing an optically active alcohol derivative by the use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-02-12 | — | — | EP | claimed |
| US-4440845-A | CHARGE TRANSFER COMPOUND | RICOH CO., LTD. (JP) | 1984-04-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210138117-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | BMP2, BMP4, BMP6 | NQO1 2074/4885TSHR 2887/4885TDP1 4775/4885 |
| US-20160038641-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | BMP2, BMP4, BMP6 | NQO1 2892/4885TSHR 3898/4885TDP1 4712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.